182 related articles for article (PubMed ID: 8390399)
1. Altered lymphocyte populations in tumour invaded nodes of breast cancer patients.
Alam SM; Clark JS; George WD; Campbell AM
Immunol Lett; 1993 Mar; 35(3):229-34. PubMed ID: 8390399
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric analysis of tumour-draining lymph nodes in breast cancer patients.
Whitford P; Alam SM; George WD; Campbell AM
Eur J Cancer; 1992; 28(2-3):350-6. PubMed ID: 1591050
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic analysis of tumor-infiltrating lymphocytes from human breast cancer.
Chin Y; Janseens J; Vandepitte J; Vandenbrande J; Opdebeek L; Raus J
Anticancer Res; 1992; 12(5):1463-6. PubMed ID: 1332579
[TBL] [Abstract][Full Text] [Related]
4. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
[TBL] [Abstract][Full Text] [Related]
5. T cell receptor gamma/delta expression on lymphocyte populations of breast cancer patients.
Alam SM; Clark JS; Leech V; Whitford P; George WD; Campbell AM
Immunol Lett; 1992 Feb; 31(3):279-83. PubMed ID: 1347754
[TBL] [Abstract][Full Text] [Related]
6. Expression of activation-related molecules on regional lymph node lymphocytes in human lung cancer.
Takenoyama M; Yasumoto K; Harada M; Matsuzaki G; Ishida T; Sugimachi K; Nomoto K
Immunobiology; 1996 Jul; 195(2):140-51. PubMed ID: 8877391
[TBL] [Abstract][Full Text] [Related]
7. [Preliminary study on lymphocyte subsets of sentinel lymph nodes in breast cancer patients].
Wang S; Fan P; Wu ZY
Zhonghua Zhong Liu Za Zhi; 2004 Apr; 26(4):220-2. PubMed ID: 15312384
[TBL] [Abstract][Full Text] [Related]
8. Phenotyping of lymphocytes expressing regulatory and effector markers in infiltrating ductal carcinoma of the breast.
Leong PP; Mohammad R; Ibrahim N; Ithnin H; Abdullah M; Davis WC; Seow HF
Immunol Lett; 2006 Feb; 102(2):229-36. PubMed ID: 16246429
[TBL] [Abstract][Full Text] [Related]
9. Immune profiles of CD4+ lymphocyte subsets in breast cancer tumor draining lymph nodes.
Faghih Z; Erfani N; Haghshenas MR; Safaei A; Talei AR; Ghaderi A
Immunol Lett; 2014; 158(1-2):57-65. PubMed ID: 24326038
[TBL] [Abstract][Full Text] [Related]
10. Lymphocyte populations in human lymph nodes. Alterations in CD4+ CD25+ T regulatory cell phenotype and T-cell receptor Vbeta repertoire.
Battaglia A; Ferrandina G; Buzzonetti A; Malinconico P; Legge F; Salutari V; Scambia G; Fattorossi A
Immunology; 2003 Nov; 110(3):304-12. PubMed ID: 14632657
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of cells from a non-invaded and an invaded lymph node with a HER-2+ tumor with peptides corresponding to T-cell epitopes E75 and G89 induced expansion of central memory cells (TCM) from the metastasis-negative lymph nodes.
Ko BK; Efferson CL; Kawano K; Kuerer HM; Sahin A; Murray JL; Ioannides CG
Int J Oncol; 2004 Jun; 24(6):1413-8. PubMed ID: 15138582
[TBL] [Abstract][Full Text] [Related]
12. Quantitative differences in CD8+ lymphocytes, CD4/CD8 ratio, NK cells, and HLA-DR(+)-activated T cells of racially different male populations.
Shahabuddin S
Clin Immunol Immunopathol; 1995 May; 75(2):168-70. PubMed ID: 7704975
[TBL] [Abstract][Full Text] [Related]
13. Characterization of cells from invaded lymph nodes in patients with solid tumors. Lymphokine requirement for tumor-specific lymphoproliferative response.
Cozzolino F; Torcia M; Carossino AM; Giordani R; Selli C; Talini G; Reali E; Novelli A; Pistoia V; Ferrarini M
J Exp Med; 1987 Aug; 166(2):303-18. PubMed ID: 2955070
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of CD8+ T cells from tumor-invaded and tumor-free lymph nodes of melanoma patients: role of common gamma-chain cytokines.
Anichini A; Scarito A; Molla A; Parmiani G; Mortarini R
J Immunol; 2003 Aug; 171(4):2134-41. PubMed ID: 12902520
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometric analysis of tumour infiltrating lymphocyte activation and tumour cell MHC class I and II expression in breast cancer patients.
Whitford P; George WD; Campbell AM
Cancer Lett; 1992 Jan; 61(2):157-64. PubMed ID: 1730139
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometric analysis of tumour infiltrating lymphocytes in breast cancer.
Whitford P; Mallon EA; George WD; Campbell AM
Br J Cancer; 1990 Dec; 62(6):971-5. PubMed ID: 2124138
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometric analysis of tumour-infiltrating lymphocytes in patients with renal cell carcinoma.
Kowalczyk D; Skorupski W; Kwias Z; Nowak J
Br J Urol; 1997 Oct; 80(4):543-7. PubMed ID: 9352689
[TBL] [Abstract][Full Text] [Related]
18. In vitro studies of axillary lymph node cells in patients with breast cancer.
Tsakraklides E; Tsakraklides V; Ashikari H; Rosen PP; Siegal FP; Robbins GF; Good RA
J Natl Cancer Inst; 1975 Mar; 54(3):549-56. PubMed ID: 1079055
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibody-defined phenotypes of regional lymph node and peripheral blood lymphocyte subpopulations in early breast cancer.
Morton BA; Ramey WG; Paderon H; Miller RE
Cancer Res; 1986 Apr; 46(4 Pt 2):2121-6. PubMed ID: 3081262
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of CD4+ and CD8+ T cells in tumor tissues, lymph nodes and the peripheral blood from patients with breast cancer.
Riazi Rad F; Ajdary S; Omranipour R; Alimohammadian MH; Hassan ZM
Iran Biomed J; 2015; 19(1):35-44. PubMed ID: 25605488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
